WallStreetZenWallStreetZen

NASDAQ: IDXX
Idexx Laboratories Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for IDXX

Based on 6 analysts offering 12 month price targets for Idexx Laboratories Inc

Min Forecast
$620.00+8.86%
Avg Forecast
$715.83+25.69%
Max Forecast
$800.00+40.46%

Should I buy or sell IDXX stock?

Based on 6 analysts offering ratings for Idexx Laboratories Inc.

Buy
Strong Buy
3 analysts 50%
Buy
0 analysts 0%
Hold
3 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although IDXX's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates IDXX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their IDXX stock forecasts and price targets.

IDXX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-07-27
lockedlocked$00.00+00.00%2026-04-15
lockedlocked$00.00+00.00%2026-03-31
lockedlocked$00.00+00.00%2026-02-09
lockedlocked$00.00+00.00%2026-02-05
BTIG
Top 1%
100
Strong BuyMaintains$800.00+40.46%2026-02-03

1 of 1

Forecast return on equity

Is IDXX forecast to generate an efficient return?

Company
108.33%
Industry
-91.28%
Market
174.76%
IDXX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IDXX forecast to generate an efficient return on assets?

Company
49.79%
Industry
15.21%
IDXX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IDXX earnings per share forecast

What is IDXX's earnings per share in the next 3 years based on estimates from 19 analysts?

Avg 1 year Forecast
$14.95+9.13%
Avg 2 year Forecast
$16.85+22.97%
Avg 3 year Forecast
$19.04+38.96%
IDXX's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

IDXX revenue forecast

What is IDXX's revenue in the next 3 years based on estimates from 19 analysts?

Avg 1 year Forecast
$4.8B+8.07%
Avg 2 year Forecast
$5.2B+17.5%
Avg 3 year Forecast
$5.7B+28.04%
IDXX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IDXX earnings growth forecast

How is IDXX forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
11.48%
Industry
17.45%
Market
33.99%
IDXX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
IDXX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
IDXX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

IDXX revenue growth forecast

How is IDXX forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
8.53%
Industry
8.17%
Market
13.75%
IDXX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IDXX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IDXX vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
IDXX$569.54$715.83+25.69%Buy
IQV$242.94$222.54-8.40%Strong Buy
A$140.54$155.36+10.55%Strong Buy
WAT$383.90$401.56+4.60%Buy
NTRA$252.22$276.69+9.70%Strong Buy
View Top Diagnostic & Research Stocks

Idexx Laboratories Stock Forecast FAQ

Is Idexx Laboratories Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: IDXX) stock is to Buy IDXX stock.

Out of 6 analysts, 3 (50%) are recommending IDXX as a Strong Buy, 0 (0%) are recommending IDXX as a Buy, 3 (50%) are recommending IDXX as a Hold, 0 (0%) are recommending IDXX as a Sell, and 0 (0%) are recommending IDXX as a Strong Sell.

If you're new to stock investing, here's how to buy Idexx Laboratories stock.

What is IDXX's earnings growth forecast for 2026-2028?

(NASDAQ: IDXX) Idexx Laboratories's forecast annual earnings growth rate of 11.48% is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 17.45%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.99%.

Idexx Laboratories's earnings in 2026 is $1,095,233,000.On average, 19 Wall Street analysts forecast IDXX's earnings for 2026 to be $1,179,371,800, with the lowest IDXX earnings forecast at $1,119,381,281, and the highest IDXX earnings forecast at $1,227,088,125. On average, 19 Wall Street analysts forecast IDXX's earnings for 2027 to be $1,328,965,515, with the lowest IDXX earnings forecast at $1,252,346,460, and the highest IDXX earnings forecast at $1,405,576,682.

In 2028, IDXX is forecast to generate $1,501,735,055 in earnings, with the lowest earnings forecast at $1,383,765,533 and the highest earnings forecast at $1,636,664,422.

What is IDXX's revenue growth forecast for 2026-2028?

(NASDAQ: IDXX) Idexx Laboratories's forecast annual revenue growth rate of 8.53% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.75%.

Idexx Laboratories's revenue in 2026 is $4,446,095,000.On average, 19 Wall Street analysts forecast IDXX's revenue for 2026 to be $379,032,800,585, with the lowest IDXX revenue forecast at $362,388,488,218, and the highest IDXX revenue forecast at $391,890,729,096. On average, 19 Wall Street analysts forecast IDXX's revenue for 2027 to be $412,084,776,328, with the lowest IDXX revenue forecast at $387,709,930,255, and the highest IDXX revenue forecast at $429,044,620,683.

In 2028, IDXX is forecast to generate $449,080,901,921 in revenue, with the lowest revenue forecast at $414,530,149,235 and the highest revenue forecast at $475,822,237,904.

What is IDXX's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: IDXX) forecast ROA is 49.79%, which is higher than the forecast US Diagnostics & Research industry average of 15.21%.

What is IDXX's Price Target?

According to 6 Wall Street analysts that have issued a 1 year IDXX price target, the average IDXX price target is $715.83, with the highest IDXX stock price forecast at $800.00 and the lowest IDXX stock price forecast at $620.00.

On average, Wall Street analysts predict that Idexx Laboratories's share price could reach $715.83 by Jul 27, 2027. The average Idexx Laboratories stock price prediction forecasts a potential upside of 25.69% from the current IDXX share price of $569.54.

What is IDXX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: IDXX) Idexx Laboratories's current Earnings Per Share (EPS) is $13.70. On average, analysts forecast that IDXX's EPS will be $14.95 for 2026, with the lowest EPS forecast at $14.19, and the highest EPS forecast at $15.56. On average, analysts forecast that IDXX's EPS will be $16.85 for 2027, with the lowest EPS forecast at $15.88, and the highest EPS forecast at $17.82. In 2028, IDXX's EPS is forecast to hit $19.04 (min: $17.54, max: $20.75).

What is IDXX's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: IDXX) forecast ROE is 108.33%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.